Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Exploring the Ethical Dimensions of Peanut Allergy Immunotherapy Research
Leukocyte Telomere Length and Cardiovascular Disease in Jackson Heart Study
Defining the Mechanisms of genotype-dependent responses to caloric restriction
Feedback Control of Respiration Induced Tumor Motion with a Treatment Couch
Purification and crystallization of human 12-LOX enzymes
Recently added grants:
Paternal DDT exposure and programming of metabolic dysfunction and cancer in offspring: Understanding the role of sperm mirnas and placenta development
The impact of reduced blood flow early in Alzheimer's disease on neuronal function.
Contribution of peripheral immune dysregulation to Alzheimer's disease
Sensitive and quantitative malaria diagnostic using nanoscale porous silicon.
Tetrahydrothieno[2,3-c]pyridines as Vaccine Co-adjuvants
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07153-17-0-1
Application #
7574913
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Johns Hopkins University
$389,122
NIH 2007
N01 HL
Pediatric Hydroxyuera Phase III Clinical Trial
Casella, James F. /
$523,182
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant